Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma

The latest issue of the American Journal of Gastroenterology reports on the long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma.

News image

Long-term outcomes after endoscopic resection provide important information for the treatment of esophageal carcinoma.

Dr Takeshi Yamashina and colleagues investigated the rates of survival and metastasis after endoscopic resection of esophageal carcinoma.

The team reported that from 1995 to 2010, 570 patients with esophageal carcinoma were treated by endoscopic resection.

Of these, the 402 patients with squamous cell carcinoma were included in our analysis.

The research team found that 17 patients had cancer invading into the submucosa up to 0.2 mm, and 35 patients had cancer invading into the submucosa more than 0.2 mm.

The mean follow-up time was 50 months.

The 5-year overall survival rates of patients with epithelial/lamina propria, muscularis mucosa , and submucosal cancer were 91%, 71%, and 71%, respectively.

The cumulative 5-year metastasis rates in patients with mucosal cancer were 47%
Am J Gastroenterology

The researchers identified depth of invasion and age as independent predictors of survival, with hazard ratios of 3.6 for muscularis mucosa cancer, and 3.2 for submucosal cancer compared with epithelial /lamina propria cancer, and 1.07 per year of age.

The cumulative 5-year metastasis rates in patients with epithelial/lamina propria, muscularis mucosa, submucosa up to 0.2 mm, and submucosa more than 0.2 mm cancer were 0.4%, 9%, 8%, and 36%, respectively. 

The research team found that identified depth of invasion as an independent risk factor for metastasis, with hazard ratios of 13 for muscularis mucosa , 40 for submucosa up to 0.2 mm, and 196 for submucosa more than 0.2 mm cancer compared with epithelial /lamina propria cancer.

The cumulative 5-year metastasis rates in patients with mucosal cancer with and without lymphovascular involvement were 47%, and 0.7%, respectively.

Dr Yamashina's team concludes, "The long-term risk of metastasis after endoscopic resection was mainly associated with the depth of invasion."

"This risk should be taken into account when considering the indications for endoscopic resection."

Am J Gastroenterol 2013; 108:544–551
23 April 2013

Go to top of page Email this page Email this page to a colleague

 25 May 2016 
Preventing NSAID-associated GI toxicity
 25 May 2016 
Recurrence of Barrett’s after successful endoscopic therapy
 25 May 2016 
PPIs and NSAID-induced small bowel injury
 24 May 2016 
Fecal inflammatory markers in Crohn's
 24 May 2016 
Depression and IBD recurrence
 24 May 2016 
New therapies for NASH
 23 May 2016 
Risk factors for peptic ulcer bleeding outcomes
 23 May 2016 
Liver transplantation for hepatocellular carcinoma
 23 May 2016 
Cancer after colectomy in IBD
 20 May 2016 
Biomarker for colorectal cancer diagnosis
 20 May 2016 
Prognostic score for hepatic venous outflow obstruction
 20 May 2016 
Treatment for uncomplicated acute diverticulitis
 19 May 2016 
Probiotics and H. pylori eradication
 19 May 2016 
Impaired skeletal health in atrophic gastritis
 19 May 2016 
Predicting outcome in ulcerative colitis
 18 May 2016 
Erectile dysfunction in IBD
 18 May 2016 
Acute GERD and esophageal histologic changes
 18 May 2016 
Surgical fundoplication for GERD 
 17 May 2016 
Mucosal dysbiosis in Crohn's disease
 17 May 2016 
Vitamin D level and clinical status in IBD 
 17 May 2016 
Inpatient costs for IBD and acute pancreatitis
 16 May 2016 
Outcomes of postcolonoscopy colorectal cancers
 16 May 2016 
C. difficile in ulcerative colitis patients
 16 May 2016 
Therapy for Crohn's in a Medicaid population
 13 May 2016 
Parkinson's disease and IBD
 13 May 2016 
Non-traditional heart disease risk factors in NAFLD
 13 May 2016 
Inactivated oral cholera vaccine
 12 May 2016 
Gestational diabetes mellitus and NAFLD
 12 May 2016 
Impact of Crohn's in the USA
 12 May 2016 
Ozanimod induction and ulcerative colitis
 11 May 2016 
Anti-TNF discontinuation in IBD
 11 May 2016 
Age and disease presentation with Crohn's disease
 11 May 2016 
Prognosis after colorectal cancer resection
 10 May 2016 
Gluten-free diet in patients with IBS-diarrhea
 10 May 2016 
Noninvasive test for IBD
 10 May 2016 
Digital health for gastroenterology
 09 May 2016 
Diarrheal infections in adults
 09 May 2016 
Quality improvement initiative and readmission for cirrhosis
 09 May 2016 
Coffee or tea and the risk of Barrett's
 06 May 2016 
Recurrent pancreatitis after acute pancreatitis
 06 May 2016 
Risk factors in peptic ulcer bleeding
 06 May 2016 
Managing acute lower GI bleeding
 05 May 2016 
Chemoradiotherapy vs chemotherapy for pancreatic cancer
 05 May 2016 
Reductions in quality of screening colonoscopies
 05 May 2016 
Genetics in early-early-onset IBD
 04 May 2016 
Anti-TNF therapy for IBD
 04 May 2016 
Bismuth and H. pylori eradication
 04 May 2016 
Chromoendoscopy vs colonoscopy for dysplasia in colitis
 03 May 2016 
Vedolizumab for IBD
 03 May 2016 
PPIs and gut microbiota
 03 May 2016 
Surgery vs medical therapy for GERD
 02 May 2016 
Mycophenolate mofetil as first-line treatment of autoimmune hepatitis
 02 May 2016 
Genetic variant that increase NAFLD risk
 02 May 2016 
Resection of colorectal polyps
 29 April 2016 
Simvastatins and survival in cirrhosis
 29 April 2016 
HCV infection in Baby Boomers with Medicare
 29 April 2016 
Crohn's disease associated genes
 28 April 2016 
Diarrheal diseases in children
 28 April 2016 
Birth outcomes in women with IBD receiving assisted reproduction
 28 April 2016 
Racial disparities in survival from colon cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us